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Multiple sclerosis (MS) is a common cause of non-traumatic neurologic disability with
high incidence in many developed countries. Although the etiology of the disease
remains elusive, it is thought to entail genetic and environmental causes, and microbial
pathogens have also been envisioned as contributors to the phenotype. We conducted
a metagenomic survey in cerebrospinal fluid (CSF) from 28 MS patients and 15 patients
suffering other type of neurological conditions. We detected bacterial reads in eight out
of the 15 non-MS patients and in a single MS patient, at an abundance >1% of total
classified reads. Two patients were of special interest: one non-MS patient harbored
∼73% bacterial reads, while an MS patient had ∼83% bacterial reads. In the former
case, Veillonella parvula, a bacterium occasionally found associated with meningitis was
the predominant species, whilst Kocuria flava, apparently an environmental bacterium,
predominated in the latter case. Thirty-four out of 43 samples contained <1%
bacterial reads, which we regard as cross- or environmental contamination. A few viral
reads corresponding to Epstein-Barr virus, cytomegalovirus, and parvovirus were also
identified. Our results suggest that CSF of MS patients is often (but not always) free of
microbial DNA.
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INTRODUCTION
Multiple sclerosis (MS) is a common inflammatory-demyelinating disease of the central nervous
system (CNS), which leads to impaired sensory, motor, cerebellar, brain stem, and autonomic
functions, and is the foremost cause of non-traumatic neurologic disability in young and middle
age patients (Giesser, 2011). At the molecular level, demyelination involves deterioration of myelin
sheaths that ensheathe axonal connection between neurons, primarily by macrophages (Comi,
2010). Because T cells mediate myelin degradation, MS is often referred to as an autoimmune
disease (Piccio and Cross, 2011). Despite intense research, the cause of MS remains elusive, but the
evidence accumulated so far points toward a multifactorial etiology, including genetic (Oksenberg,
2013; Cree, 2014; Sawcer et al., 2014; Axisa and Hafler, 2016) and environmental (O’Gorman
et al., 2012; Ascherio, 2013; Malli et al., 2015) factors. In Caucasian cohorts, MHC haplotypes
have been found strongly associated with MS (McFarland and Martin, 2007). Some environmental
predisposing factors have also been identified, including vitamin D deficiency, smoking, and
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women are twice as susceptible as men, possibly due to a
neuroprotective role of testosterone (Gold and Voskuhl, 2009).
Although the disease is distributed worldwide, it holds a
positive correlation with latitude, and foci of high incidence
are rather patchy across the globe, suggesting that some
ethnic groups are more susceptible than others (Ramagopalan
and Sadovnick, 2011; Pantazou et al., 2015) or that locally-
concentrated infectious microbes may be associated with disease
biogenesis (Comi, 2010; Libbey et al., 2014). Furthermore, in a
large cohort of patients (n > 40,000) from Canada, Great Britain,
Denmark, and Sweden, it was found that significantly fewer
people suffering MS were born in November, while significantly
more MS patients were born in May, which might point to
seasonal oscillations in vitamin D or infectious agents, which
in turn may interact with genetic factors since the effect was
heightened in familial cases (Willer et al., 2005).
Cerebrospinal fluid (CSF) is a clear, non-viscous, material
with a very low content of proteins, potassium, and glucose,
when compared to plasma, but higher content of chloride
and sodium, which maintains CSF neutral charge (Davson
and Segal, 1996). It is believed to originate predominantly
as a secretion of the choroid plexuses in the ventricles of
the brain, upon filtering of plasma through choroid epithelial
cells (Davson and Segal, 1996), although this hypothesis
has been challenged and instead was proposed that CSF
also originates in other compartments of the CSF system
(Oreškovic´ and Klarica, 2016). CSF localizes to the brain
ventricles and subarachnoid space and also surrounds the spinal
cord (Davson and Segal, 1996). In addition to mechanical
cushion or buoyancy for the cortex, CSF also provides
immunological protection to the brain (Nathanson and Chun,
1989), chemical stability (Praetorius, 2007), among other
functions.
The presence of immunoglobulins (IgG) in CSF in a
large proportion of patients undergoing neurological disorders
suggests that at least some of those diseases might have an
infectious etiology (reviewed in Das Sarma, 2010). For instance,
IgG with specificity against measles virus was found in patients
suffering subacute sclerosing panencephalitis (Connolly et al.,
1967; Connolly, 1968); similarly, antibodies against Cryptococcus
have been found in CSF of meningitis patients (Porter et al.,
1977). A wide range of microorganisms has been proposed as
putative cause for MS (Johnson, 1994; Swanborg et al., 2003;
Stuve et al., 2004; O’Gorman et al., 2012; Zawada, 2012; Libbey
et al., 2014). Many studies have also reported the association
of Herpes viruses and MS (Warren et al., 1977; Merelli et al.,
1997; Moore and Wolfson, 2002; Kuusisto et al., 2008), and the
gut microbiome of MS patients exhibit a different profile than
that from paired control subjects (Chen et al., 2016; Jangi et al.,
2016). It is not clear how antigen-presenting cells in the CNS
can interact with activated lymphocytes in the periphery, but it
has been proposed that the choroid plexus may display antigens
in CSF, likely presented by astrocytes or glial cells, to peripheral
blood cells through the choroid epithelium (Nathanson and
Chun, 1989).
Since MS is a demyelinating disease, logic would suggest
that potential pathogens influencing the disease should also
be able to induce demyelination. Several species of bacteria
have been reported invading the CNS (Casserly et al., 2007),
includingMycoplasma pneumoniae (Abramovitz et al., 1987) and
Chlamydia pneumoniae (Sriram et al., 1999). M. pneumoniae
reportedly induces demyelination (Greenlee and Rose, 2000)
but this finding has not been replicated by other investigators
(Casserly et al., 2007; Lindsey and Patel, 2008). Another
hypothesis emerging from animal models suggests that bacterial
superantigens (e.g., Staphylococcus aureus enterotoxins A, B, C,
D, and E) activate auto-reactive T cells, which then promotes
the onset of immune diseases like MS (Brocke et al., 1993).
Indeed, a significant proportion of patients with relapsing MS
(within 30 days) were positive for S. aureus enterotoxin A
as compared to subjects without MS (Mulvey et al., 2011).
For viruses, several mechanisms of demyelination have been
proposed, including viral lysis of infected oligodendrocytes or
immune lysis of uninfected oligodendrocytes specifically or
non-specifically triggered by the viral infection (reviewed in
Libbey et al., 2014). While microbes are attractive candidates
for triggering MS, the environmental triggers for disease have
yet to be determined, reflecting limited sensitivity of techniques
applied for microbial detection as well as concomitant problems
of contamination of samples. Accordingly, we sought to analyze
the composition of DNA circulating in CSF from patients affected
by MS or other neurological conditions, using an unbiased
metagenomics approach to identify possible microbial triggers
of MS. Our main findings suggest that CSF is often a microbial
DNA free environment, but occasionally can be loaded with
bacterial DNA. Virus-like sequences were initially detected,
but upon careful examination most sequences turned out to
be spurious hits belonging to contaminating DNA. A limited
fraction of the reads may correspond to bona fide herpesviruses
and parvoviruses.
RESULTS
Most Multiple Sclerosis (MS) Samples Are
Free of Bacterial DNA
We initially attempted to extract DNA from 78 CSF samples
from patients affected by MS or other neurological conditions.
However, only 30 of those samples produced detectable
levels of DNA, and we used them for the construction of
metagenomics libraries (samples are described in Table 1). We
also used non-measurable amounts of DNA from non-MS
patients, and could obtain libraries suitable for sequencing
from 15 samples, but it required a higher number of PCR
amplification cycles. Hereafter, samples derived from multiple
sclerosis patients are denoted by the letters “MS” while the
rest are designated as “non-MS” or “control” samples. In
a previous study to assess sensitivity of metagenomics for
detection of microbial DNA in CSF, it was shown that
libraries from cell cultures spiked in with only viral nucleic
acids may yield up to ∼4% of bacterial sequences, suggesting
environmental contamination (Bukowska-Os´ko et al., 2017).
Using this frequency as a somewhat arbitrary threshold, we
found that 4 out of 15 (∼27%) non-MS samples contained more
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TABLE 1 | Description of samples and results of Kraken alignments in regards to the most abundant groups detected (human, bacteria, viruses, and
archaea).
Sample Diagnostic Gender Human (%) Bacteria (%) Viruses (%) Archaea (%)
1C 6th nerve palsy M 99.32 0.03 0.0005 0.0009
2C Subarachnoid hemorrhage M 98.88 0.20 0.004 0.006
3C Trigeminal neuralgia F 27.46 73.48 0.03 0.09
4C Hypochondriasis F 95.64 4.77 0.04 0.04
5C Chiari type I F 83.37 15.93 0.009 0.05
6C Hypertension M 99.7 0.20 0.002 0.001
7C FNS F 91.99 6.77 0.02 0.09
8C Spasticity M 98.57 1.49 0.01 0.002
9C Idiopathic M 99.36 0.31 0.01 0.006
10C Parkinson M 97.14 2.96 0.006 0.01
11C Low back pain M 99.96 0.11 0.003 0.005
12C Sciatica F 81.25 18.26 0.09 0.07
13C IC hypertension F 99.79 0.29 0.003 0.003
14C IC hypertension F 97.70 1.94 0.003 0.007
15C IC hypertension F 97.10 0.30 0.001 0.002
1MS Multiple sclerosis F 99.25 0.27 0.007 0.001
2MS Multiple sclerosis M 99.80 0.10 0.002 0.002
3MS Multiple sclerosis F 99.07 0.21 0.003 0.001
4MS Multiple sclerosis M 99.51 0.03 0.001 0.03
5MS Multiple sclerosis F 99.99 0.00 0.001 0.002
6MS Multiple sclerosis M 99.51 0.04 0.003 0.00
7MS Multiple sclerosis M 99.97 0.02 0.001 0.0002
8MS Multiple sclerosis F 99.13 0.09 0.0009 0.0005
9MS Multiple sclerosis M 99.51 0.10 0.002 0.002
10MS Multiple sclerosis M 99.96 0.31 0.002 0.001
11MS Multiple sclerosis M 99.81 0.02 0.00 0.01
12MS Multiple sclerosis F 99.67 0.05 0.0003 0.002
13MS Multiple sclerosis M 99.96 0.09 0.002 0.001
14MS Multiple sclerosis M 99.81 0.02 0.002 0.0005
15MS Multiple sclerosis F 99.73 0.03 0.0006 0.0008
16MS Multiple sclerosis F 99.81 0.11 0.001 0.00
17MS Multiple sclerosis F 99.45 0.07 0.002 0.001
18MS Multiple sclerosis F 99.78 0.11 0.002 0.002
19MS Multiple sclerosis M 99.96 0.01 0.0004 0.002
20MS Multiple sclerosis F 99.96 0.31 0.001 0.001
21MS Multiple sclerosis F 99.84 0.21 0.001 0.003
22MS Multiple sclerosis M 99.91 0.07 0.003 0.0002
23MS Multiple sclerosis M 99.96 0.11 0.002 0.001
24MS Multiple sclerosis M 99.98 0.04 0.0004 0.0008
25MS Multiple sclerosis F 99.99 0.03 0.001 0.0002
26MS Multiple sclerosis F 16.99 83.25 0.04 0.08
27MS Multiple sclerosis F 99.98 0.06 0.0003 0.0005
28MS Multiple sclerosis M 99.96 0.12 0.001 0.002
Boldface rows correspond to samples that contained more than 5% of bacterial reads.
than 5% of bacterial reads (Figure 1, Figure S1, and Table 1),
while only a single MS sample out of 28 (∼3.6%) was found
to harbor more than 5% of bacterial reads. Interestingly, all
those samples correspond to female patients. The rest of libraries
also had some bacterial reads, but at very low abundance,
with 34 out of 43 libraries containing <1% bacterial reads
(Tables 1, 2).
Two patients are of special interest (3C and 26MS).
Patient 3C and 26MS harbored ∼73 and 83% bacterial reads,
respectively. The taxonomical bacterial profile of both samples
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FIGURE 1 | Taxonomic classification of samples 3C (A) and 26MS (B) performed by Kraken and plotted with Krona.
TABLE 2 | Mean, standard deviation, and median abundance of human, bacterial, viral, and archaea DNA per group.
Group Human Bacteria Viruses Archaea
Mean [sd] Median Mean [sd] Median Mean [sd] Median Mean [sd] Median
Non-MS 91.1 [19.1] 97.7 8.5 [19.4] 1.5 0.02 [0.02] 0.006 0.03 [0.03] 0.006
MS 96.8 [15.6] 99.8 3.1 [15.7] 0.1 0.003 [0.007] 0.001 0.005 [0.02] 0.001
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was significantly different, excluding the possibility of cross-
contamination between them (Figure 1). The sample from
patient 3C was mainly populated with reads that resemble
Veillonella parvula, and to a lesser extent Streptococcus gordonii
and S. sanguinis and few other species of lower abundance
(Figure 1A). Sample from patient 26MS was overwhelmingly
populated by three species of Kocuria (flava, palustris, and
rhizophila) and a series of non-abundant bacteria (Figure 1B). To
exclude the possibility that an abundant and highly redundant
sequence was producing spurious alignments to one or few
loci in the genome of those two overrepresented bacteria, we
plotted the relative abundance of reads along the whole genome
of V. parvula (Figure 2A) and Kocuria flava (Figure 2B). The
relatively homogeneous distribution of reads along the genome
of those two bacteria suggests that those bacterial genomes
FIGURE 2 | Frequency histogram of relative abundance of reads
aligning to different parts of the genome of Veillonella parvula (A) or
Kocuria flava (B).
were present in the sequenced pool of DNA, and excludes the
possibility of artifactual alignments.
To gain insights into the relationships between samples, we
conducted principal component analysis (PCA; Jovel et al., 2016).
PCAwas conducted on any taxon that was detected in at least one
sample (n= 559; Supplementary Table 1). The first Eigen vector
of the PCA separated samples that contained more than 1%
of bacterial reads from those that contained <1% (Figure 3A).
This positioned samples 3C, 4C, 5C, 7C, 8C, 10C, 12C, and
14C on the left of the rest of control samples and somewhat
proximal to each other (Figure 3A). The second Eigen vector of
the PCA clearly separated sample 26MS from the rest of samples
containing bacterial reads. Samples that contained<1% bacterial
reads clustered together in the northeast quadrant of the plot,
irrespectively of being MS or non-MS (Figure 3A). To refine
our analysis, we conducted hierarchical clustering. In hierarchical
clustering, an iterative algorithm positions samples with similar
bacterial profiles closer on the branches of a dendrogram, while
more dissimilar samples will branch apart (Jovel et al., 2016).
The most ubiquitous bacterial species were Propionibacterium
acnes and Alteromonas mediterranea, with the former bacterium
previously found as contaminant in our libraries (Jovel et al.,
2016). As deduced from the PCA analysis, all samples in the
control group with more than 1% of bacterial reads clustered
together in a single node (green node in upper dendrogram)
with some minor subgroups (Figure 3B). For the samples in this
cluster, the most-densely populated with bacterial reads (3C; red
node on upper dendrogram; leftmost column in heatmap) might
have acted as a contamination source, especially for samples that
were sitting nearby in the same rack during library construction,
since samples were ordered numerically on the rack. The fact
that samples 4C, 5C, 7C, and 8C were also found to contain
bacterial reads, supports the cross-contamination hypothesis.
Accordingly, the profile of bacterial reads relative abundance
depicted in the heatmap is similar, but not identical, between
control samples than contained more than 1% of bacterial reads
(Figure 3B). Noticeably, there are two conspicuous blocks of
bacterial taxa that appear to be absent from most samples, but
commonly represented in the control samples with more than
1% of bacterial reads. When such bacterial sets were zoomed in,
a large number of bacterial species are evident, with the genera
Streptococcus, Pseudomonas, and Bacteroides being among the
most frequently detected (blue font in Figure 3C). The most
abundant species in non-MS samples, V. parvula, appeared
represented in five out of the eight control samples, but at high
frequency only in sample 3C. As before, theMS sample harboring
a large proportion of bacterial reads clearly separated from non-
MS sample (blue node on upper dendrogram in Figure 3B).
K. flava, the most abundant bacterial species in sample 26MS
(73,796 reads) was found in some other samples (2MS, 18MS,
2C, 13C, 10MS, and 7C) but at a maximal abundance of 35
reads per library. Based on our previous experience, we regard
that as cross-contamination. In addition to K. flava, sample
26MS contained a series of bacterial taxa of various abundances,
which were only rarely seen in other samples (Figure 3B, cyan
frame, Supplementary Table 1, colored red). In general, samples
that are located close to each other on the wetlab rack can be
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FIGURE 3 | Illustration of compositional relationship of samples as assessed by principal component analysis (A) and hierarchical clustering (B). In (C), a
close-up of some bacterial taxa frequently detected is shown.
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considerably contaminated while trace cross-contamination may
happen between all tubes, likely when DNA is aerosolized.
Spurious Viral Hits
In addition to phage sequences, the most prevalent virus detected
was the Human immunodeficiency virus 1 (HIV-1) and the
herpes viruses 5 and 7. Although, at very low abundance
(1–16 reads per library) the high frequency of HIV-1 sequences
was rather suspicious and prompted us to inspect such hits
more carefully. We extracted the raw reads that aligned to
all viruses, and remove those ones corresponding to phages
hits. The rest was aligned with BLAST against the whole “nt”
database of NCBI. As expected, the HIV-1 hits were spurious
since better hits either to lentiviral vectors or to a draft
genome of the bacterium Ralstonia solanacearum were identified
(Supplementary Table 2). On a closer inspection of the Ralstonia
draft genome, we observed that the draft genome contains
many sequences resembling Illumina adapters, which create
artifactual alignments (Figure S2). A few sequences that were
originally classified as cytomegalovirus (Human herpesvirus 5),
Esptein-Barr virus (Human herpesvirus 4), parvoviruses or
Paramecium chlorella bursaria virus were also confirmed as
such during re-alignments (Supplementary Table 2, colored
red). Thus, it is possible that such viruses are bona fide
colonizers of CSF. In addition, sequences originally classified as
Encephalomyocarditis virus were reclassified as Human simplex
virus (Human herpesvirus 1). Some viral sequences that likely
are associated with food, including Beet curly top virus and
Iridoviruses also were confirmed during realignments.
Bacterial and Human Cells Were Scarce in
CSF
Reads mapping to the human genome spanned all chromosomes
(Figures 4A,B). However, bacterial and human sequences
detected in CSF need not be from intact circulating cells; they
can also be from cell-free DNA. To distinguish between these
two possibilities, we stained CSF with Alexa Fluor-594 phalloidin
and DAPI. Phalloidin specifically stains human cells, while
DAPI intercalates the DNA of both human and bacterial cells,
which can ultimately be distinguished by size. We first prepared
a control sample that was spiked with Escherichia coli and
human THP-1 monocytes, and both human (red) and bacterial
(blue) cells were readily detected after staining (Figure 4C).
However, when we stained CSF samples, entities resembling
stained bacteria or human cells were rarely found under
fluorescence microscopy [Figure 4D (human and bacterial cells)
and Figure 4E (human cells)]. Indeed, we screened all CSF
samples described in Table 1, and with the exception of sample
26MS, we were unable to detect cell- or bacteria-like structures.
DISCUSSION
It has been a long-standing debate whether or not pathogens are
involved in the etiology of multiple sclerosis (MS; Swanborg et al.,
2003; Ramagopalan and Sadovnick, 2011; O’Gorman et al., 2012).
Several lines of evidence suggest an infectious etiology. First,
immunoglobulins with specificity against viruses or bacteria have
been found in CSF from MS patients (Belbasis et al., 2015).
Second, several bacteria, fungi, and viruses have been linked
with demyelination (Johnson, 1994; Greenlee and Rose, 2000;
Purzycki and Shain, 2010). Third, the differential geographical
distribution of the disease (Giovannoni et al., 2006), the high
incidence in developed countries (consistent with the hygiene
hypothesis; Gilden, 2005), and changing incidence in subjects
born in different seasons of the year (Willer et al., 2005), all might
point toward pathogens as causal agents of MS.
A number of studies have reported the presence of pathogens
in cerebrospinal fluid (CSF) from MS patients (Merelli et al.,
1997; Moore and Wolfson, 2002; Swanborg et al., 2003; Stuve
et al., 2004; Holmoy and Vartdal, 2005; Purzycki and Shain,
2010; Morandi et al., 2015), but the reproducibility of these
experiments was often lacking (Casserly et al., 2007; Lindsey
and Patel, 2008; Belbasis et al., 2015). Interestingly, a meta-
analysis only found evidence of association of MS with smoking,
IgG seropositivity to Epstein-Barr virus (EBV) nuclear antigen
(EBNA) and infectious mononucleosis (Belbasis et al., 2015).
Several experimental limitations might account for such a
discrepancy. First, it may be that antibodies or PCR primers
used for detection of pathogens lacked specificity and picked
up background signal. Second, environmental contaminants
are always a liability when conducting diagnostics in clinical
samples. We applied metagenomics for the unbiased detection of
microbial DNA in CSF samples from patients diagnosed with MS
or other neurological conditions used as a comparison group.
Despite the limited size of the cohort of patients analyzed in
this study (28MS and 15 non-MS patients), our results suggest
that CSF is often (but not always) free of bacteria and viruses, but
always contain human DNA. However, we also need to entertain
the hypothesis that some of the patients from our comparison
group contained a higher frequency of microbial reads for
some unknown reasons. The low background of bacterial
reads observed across all libraries (<1%) likely represents
cross-contamination events or environmental contamination
that could have happened during sample collection, nucleic
acids extraction, library preparation, or carry over in the
sequencing instrument (i.e., from previous sequencing runs with
libraries that contained the same barcodes used in this study).
Contamination of libraries is a major concern when conducting
next generation sequencing experiments (Jovel et al., 2016).
Samples with more than 1% of bacterial reads likely reflect
bona fide samples colonized with bacteria and/or bacterial DNA,
with the highly abundant ones being less likely of representing
contamination events.
Only one out of 28MS samples contained a significant fraction
of bacterial reads (83.25%), while eight out of 15 non-MS samples
contained more than 1% of bacterial reads. On average, 19 and
24 PCR cycles were required for amplification of MS and non-
MS libraries. The larger number of re-amplification cycles for
non-MS samples means that such samples were manipulated
more intensively than MS ones (i.e. each amplification PCR
is followed by a clean up step with paramagnetic beads to
remove low molecular weight material), which implies that non-
abundant environmental contaminants may have been amplified
and chances for cross-contamination increase.
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FIGURE 4 | Distribution of human reads along all chromosomes of the genome in non-MS (A), or MS (B) samples. (C) Staining of control bacterial
(Escherichia coli) and human (THP-1 monocytes) cells with phalloidin and DAPI. Human cells are shown in red and bacterial cells are shown in blue. (D) A few bacterial
cell-like structures and one human cell-like structure in sample 26MS. (E) A single cluster of putative human cells in sample 26MS from a different area of the slide. All
other samples did not have any visible structure resembling human or bacterial cells. White and cyan arrowheads point to human and bacteria cells in (C) and to
putative human and bacteria cells in (D).
In the non-MS sample with high load of bacterial DNA (3C),
the most abundant species was V. parvula, a non-fermentative
gram-negative coccus that is usually found colonizing the
oral cavity, GI tract and vagina, but occasionally has been
reported associated with meningitis (Bhatti and Frank, 2000) and
other opportunistic infectious diseases in immunocompromised
individuals (Strach et al., 2006). The most abundant species
in sample 26MS was K. flava, an actinobacterium previously
described as an airborne or a soil bacterium (Zhou et al., 2008;
Achala et al., 2011). Thus, the association of such bacterium with
MS is unclear. In summary, both Veillonela parvula in sample
3C and Kocuria spp. in sample 26MS are likely genuine bacteria
colonizing the CSF of these patients. Literature reports on a
putative role of bacteria on MS are rather discordant and hint to
M. pneumoniae, C. pneumonia, and S. aureus as possible causal
agents (Abramovitz et al., 1987; Brocke et al., 1993; Sriram et al.,
1999; Libbey et al., 2014); this is incongruent with our main
results.
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A few viral sequences belonging to Epstein-Barr virus,
cytomegalovirus and parvoviruses may be truly associated with
CSF and may be involved in the etiology of MS, as previously
suggested (Warren et al., 1977; Merelli et al., 1997; Moore
and Wolfson, 2002; Swanborg et al., 2003; Stuve et al., 2004;
Franciotta and Lolli, 2005; Gilden, 2005; Giovannoni et al., 2006).
That only few viral-like sequences were detected in our libraries
is not unexpected; this is dictated by the overwhelmingly much
higher relative abundance of human and bacterial reads.
MATERIALS AND METHODS
Study protocols and consent form was approved by the Health
Research Ethics Board, University of Alberta (HREBA). All
patients read and signed the consent form before sample
collection.
DNA Extraction, Construction of Libraries,
and Sequencing
DNA from 48 multiple sclerosis (MS) patients and 30 patients
with other neurological conditions was extracted from 200µl of
cerebrospinal fluid (CSF) using the Qiagen blood DNA mini kit,
according to manufacturer’s instructions. Only 28 MS samples
produced DNA in amounts measurable by Qubit dsDNA HS
assay kit (Invitrogen), all of them in the sub-nanogram perµl
range. Only two non-MS samples produced DNA in measurable
quantities (∼0.3 ng/µl).
For construction of metagenomics libraries, the Nextera XT
(Illumina) technology was used. In brief, 2 ng of DNA were
tagmented (or whatever was available in 5µl of DNA suspension)
with 5µl ATM for 5 min at 55◦C. The tagmentation reaction was
stopped with 5µl of NT buffer and further incubation for 5 min
at room temperature. Subsequently, the tagmentation products
were PCR amplified in the presence of a distinct barcode for
each sample, for 19 cycles in the case of MS, while non-MS
samples needed on average 24 amplification cycles to obtain
libraries in quantities sufficient for sequencing. After removal of
primer dimers and lowmolecular weight materials, libraries were
diluted to a concentration of 4 nM and pooled for sequencing.
Sequencing was conducted in a MiSeq (Illumina) instrument,
using a 600 cycles V3 kit and a workflow that includes adapter
removal and demultiplexing.
Bioinformatics Analyses
Demultiplexed reads were aligned against a customized
database using the ultrafast metagenomic classification package
Kraken (Wood and Salzberg, 2014), and abundance estimates
were generated with the package Bracken (Lu et al., 2016),
which performs a Bayesian re-estimation of abundance after
classification with Kraken. Plots were generated either with
Krona (Ondov et al., 2011; hierarchical taxonomy plots) or
using in-house R scripts. Reads that were reported by Kraken
as virus hits were extracted from the row data and then aligned
with BLAST against a recent version of the nt database of NCBI
and top hits were retrieved for taxonomy comparison against
Kraken classification by visual inspection of the corresponding
alignments.
Staining of Bacterial and Human Cells
For each patient, 50µl of CSFwas added to 150µl of RPMImedia
or E. coli HB101 (105 CFU/ml) and THP-1 human monocytes
(2.5 × 104 cells) to 200µl of RPMI on a 12 mm round coverslip
(VWR) in a 24 well plate. The plate was spun at 1000× g for
5 min and the supernatant removed. Coverslip was fixed with
4% paraformaldehyde (Fisher Scientific) for 15 min and washed
thrice with 1X PBS. Coverslips were then blocked (2% Goat
serum, 1% BSA) for 15 min. Actin was stained with Alexa Fluor-
594 phalloidin (1:40 dilution, 0.1% Triton, 0.2% Goat Serum,
and 0.1% BSA, Fisher Scientific); 4′, 6-diamidino-2-phenylindole
(DAPI) (1:1000 dilution) was used for nuclear staining (0.1%
Triton, 0.2% Goat Serum, and 0.1% BSA) and mounted using
FluorSave (Calbiochem). Slides were analyzed using Zeiss Axio
Observer.Z1 microscope with ZEN Imaging software (Carl Zeiss
Canada Ltd., Toronto, ON, Canada) and the illustrations were
edited using Image J.
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Figure S1 | Relative abundance of bacteria found in samples 12C (A), 7C
(B), and 5C (C). For the sake of clarity, only the percentage of bacterial reads are
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Figure S2 | Spurious virus alignments that also aligned to Ralstonia
solanacearum are identical to Illumina adapters and transposase
sequences. (A) Sequences identical to the Illumina Nextera PCR primer i5 index
N508. (B) Sequences identical to the Illumina Nextera PCR primer i7 index N711.
(C) Sequences identical to the Illumina Nextera transposase sequence Read 2.
(D) Sequences identical to the Illumina Nextera transposase sequence Read 1.
Supplementary Table 1 | Results of Kraken/Bracken classification and
quantification per sample. Some taxa with very low estimates of abundance
(e.g., herpesviruses) are by default excluded by Bracken estimations.
Supplementary Table 2 | Results of realignment of eukaryotic viral hits
from Kraken with BLAST against the “nt” database of NCBI. In the “Query
ID” column, the name of the sample, the name of the subject sequence originally
identified by Kraken classification and the read name in the original FASTQ files are
indicated.
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